drugset / Trial / NCT01297634

Radial Diffusion of the Botulinum Toxin Type A (Botox®): Electromyographic Evaluation of the Frontal Muscle

NCT01297634 ↗

Phase 4 Completed 64 enrolled Ivo Pitanguy Institute Allergan · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This study evaluates the diffusion area (cephalic, lateral, medial and caudal points) of the botulinum toxin type A in the frontal muscle for usual concentrations and dilutions of the drug. A basal line control and After the application control will be made, and the investigators will evaluate the drug effects, based on clinical aspects, photographic registers and through electromyography exam (EMG). Considering the results of our investigation, the investigators may propose a pattern of application of BOTULINUM TOXIN TYPE-A Botox® in the frontal area.

Timeline

Start
2011-05
Primary completion
2011-11
Completion
2011-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 1 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 2 iu Intramuscular
Subject Botulinum toxin type A Protein / enzyme biologic 3 iu Intramuscular

Indications

No indication recorded.